Rapid Therapeutic Science Laboratories, Inc. · OTC:RTSL
Rapid Therapeutic Science Laboratories — Investor Presentation (October 2021)
21 slides from Rapid Therapeutic Science Laboratories's investor presentation, Oct 12, 2021
Slide 1: Rapid Therapeutic Science Laboratories: Building the World's Best Hemp Delivery Devices
Advenced Bio Tech Rapid Therapeutic Science Laboratories Building the World's Best Hemp Delivery Devices safe. reliable. effective. fast-acting
Slide 2: Forward-looking statements disclaimer
Statements in this presentation regarding Rapid Therapeutic Science Laboratories, Inc. (RTSL) that are not, historical facts are forward-looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such
Slide 3: Ten Reasons to Invest
Ten Reasons to Invest Ih Firm commitment of minimum $1 0 milion fully underwritten offering with -1 files. SEC accepted with no review. IMM Clean balance sheet - less than $200,000 in Long Term Debt. Ih Management has 75+ years of successful private/public company experience plus in the Cannabis dom
Slide 4: Superior delivery systems and formulations
We believe superior delivery systems and formulations are the way that cannabis and supplement companies can start to separate themselves from the pack. Rapid Therapeutic Science Laboratories (RTSL) Is focused on providing our customers with the most therapeutic and effective solutions. As a biotech
Slide 5: Bioavailability and metered dose inhalers
What about being confident that you're actually going to get more every time you're looking for relief? Isn't that better, too? We believe it is, which is why we use Metered Dose Inhalers, or MDI, for our products. When taking any kind of supplement, the faster that the highest amount of the active
Slide 6: Lung Aerosol Delivery System: Metered Dose Inhaler
to Lund Aerosol Delivery System — Metered Dose Inhaler (“MDI”) An Aerosol Delivery System is a device that takes a bulk liquid formulation and disperses it into aerosol droplets appropriate for inhalation. Figo 3.10 Gas exchange between beck andeapnes from the pulmonary artery gr to the pulmonary ve
Slide 7: Nhaler
Bihaler make it yours. YK Its ene of those. Onli ne, ad its diferent chill Le fh § rd ~ “N move ~~ Lt aa Inhaler IND The use of CBD Is exploding across the US and the world and there are all kinds of stories and information about its therapeutic uses. We believe the key to safe and effective CBD use
Slide 8: RTSL filing an Investigational New Drug Application with the FDA
lM RTSL is filing an Investigative New Drug Application (IND) with ‘the FDA for its CBD MOI. Jim] Compressed air cannot be used in an MDI. (Physics applies to medical devices and the human body's physiology). IM RTSL filling equipment, cans, valves, and actuators are already FDA approved and listed
Slide 9: RTSL's MDIs Give Better, Faster Relief
RTSL's MDls Give Better, Faster Reflief RTSL’s Metered Dose Inhalers (MDIs) deliver accurate, safe, fast-acting, highly bioavailable, cost-effective relief compared to leading cannabinoid delivery systems (es igstieor pest outeot aniston) 6 ACCURATE DOSING ‘xg a QUALITY INGREDIENTS » BIOAVAILABILITY
Slide 10: MDIs safely used for years worldwide
MDIs have been safely and conveniently used for almost 70 years worldwide to treat pulmonary disease (COPD). When MDI is properly formulated and correctly used, all you must do is inhale (actuate), Upon actuation, you consume either a 2.5 or a 5 mg dose of a cannabinoid or a blend of multiple cannab
Slide 11: Additional features of the RTSL MDI
Additional ; exact metered dose of cannabinoids into your lungs for immediate absorption into your bloodstream... then straight to your brain. The RTSLMOE “Provides precise and accurate dose Requires no heat or fire Contains multiple doses ‘Is noxpensive Ascasy to use +s portable ad fits inyour pock
Slide 12: Quality Ingredients
Quality Ingredients Designed for the Medical Community RTSL MDIs only use 99.9% pure pharmaceutical-grade cannabinoids.
Slide 13: Cost per mg and 98% bioavailability
Cannabinoids cost approximately $0.30 per mg in the bloodstream at retail pricing through RTSL’s MDI. Significantly more cost-effective than vape pens which deliver CBD to the bloodstream for an average of about $1.25 per mg or ingestible CBD products averaging around $0.80 per mg. Understanding 98%
Slide 14: Product formulations and Yoka launch
(cap ant CHG: uppers enrcedpan conta lamas, ad any (C26: Spots pn management io sang atest (cap ent Cen Sipps top, ‘cor andor THCva or talcopories Supper Ws. ‘ublogs says xs na vg RSLs roy phamaceuel adele inten fr ub vas snares. ProuctLin sing esttin Pras van cia ial (caD tag depression, sansaty Yo
Slide 15: Nhaler consumer lifestyle brand
Our Nhaler brand is our consumer-facing lifestyle brand. The goal of the brand is to expand the reach of the product beyond the normal CBD consumer and allow our product extensions to fit the lifestyle needs that any consumer needs. “heard ay tv SEO antl atetirg wh eau logs ur, an Dl inc tna gia jou
Slide 16: Yoka Sublingual Spray
Yoka Sublingual Spray [ae Yoka is our consumer-focused sublingual mouth spray aimed at meeting the needs of a young consumer demographic. We know that our aerosol delivery will allow for better absorption and bioavailability of our active ingredients than drinks, pills, and gummies, Yoka Is poised t
Slide 17: Laboratory
Laboratory Our immediate focus was creating a lab that allowed us to produce the highest quality products in line with FDA standards. The new lab space that we are currently building out will be certified as an IS013485 clean room. This facility will allow us to produce products using current Good M
Slide 18: Current Capital Structure
Current Capital Structure Equity as of Sept 13, 2021 Restricted Shares 45.7% 193,516,921 Shares Outstanding 162,659,995 Restricted Shares ‘Shares Outstanding 54.3% 30,856,926 Total Shares in the Float
Slide 19: Management Team
Management Team DONAL R. SCHMIDT, JR. (59) CEO/COB HUGHES WATLER (70) CFO/ Board Member SEAN BERRIER (48) Senior VP to Rxoid TM, president of several public companies; Licensed attorney, CPA, MBA Finance, University of Texas, Degrees in Math and Chemistry. CPA with 25+ years of senior management exp
Slide 20: ‘ane Denn hts fis PD. and as cr yas ofc inary sqspmer desl an
‘ane Denn hts fis PD. and as cr 20 yas ofc inary sqspmer desl an erbchaneveepmen 5 arin sori bry esr eavoen 10 erin te paras nthy e amore eas a rope sch Hepa ata ity vrs ieie’scorol RTS gat ott oss 2 pt 2a ep Cres ander Srey Sue praca COO tos che tepals “eth and ins ruts eng Conse ‘rus sopesnin math
Slide 21: Advanced Bio Tech contact details
Advanced Bio Tech Rapid Therapeutic Science Laboratories 15800 Dooley Road, Suite 200 Addison, Texas 75001 Phone: 800-497-6059 Fax: 877-676-8527 Email: info@rtsleo.com Corporate Website: www.rtsico.com Branded Website: www.rxoid.com Contact: Don Schmidt, CEO Building the World's Best Hemp Delivery D
Rapid Therapeutic Science Laboratories — Investor Presentation (October 2021) on 6ix